Bone morphogenetic protein-2 enhances the osteogenic differentiation capacity of mesenchymal stromal cells derived from human bone marrow and umbilical cord

Marupanthorn,Kulisara; Tantrawatpan,Chairat; Kheolamai,Pakpoom; Tantikanlayaporn,Duangrat; Manochantr,Sirikul

doi:10.3892/ijmm.2017.2872

Bone morphogenetic protein-2 enhances the osteogenic differentiation capacity of mesenchymal stromal cells derived from human bone marrow and umbilical cord

Authors:
- Kulisara Marupanthorn
- Chairat Tantrawatpan
- Pakpoom Kheolamai
- Duangrat Tantikanlayaporn
- Sirikul Manochantr
View Affiliations

Affiliations: Division of Cell Biology, Department of Preclinical Sciences, Faculty of Medicine, Thammasat University, Pathum Thani 12120, Thailand
Published online on: February 1, 2017 https://doi.org/10.3892/ijmm.2017.2872
Pages: 654-662
Copyright: © Marupanthorn et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Mesenchymal stromal cells (MSCs) are multipotent cells that can give rise to different cell types of the mesodermal lineages. They are powerful sources for cell therapy in regenerative medicine as they can be isolated from various tissues, and can be expanded and induced to differentiate into multiple lineages. Recently, the umbilical cord has been suggested as an alternative source of MSCs. Although MSCs derived from the umbilical cord can be induced to differentiate into osteoblasts with a phenotypic similarity to that of bone marrow-derived MSCs, the differentiation ability is not consistent. In addition, MSCs from the umbilical cord require a longer period of time to differentiate into osteoblasts. Previous studies have demonstrated the benefits of bone morphogenetic protein-2 (BMP-2) in bone tissue regeneration. In addition, several studies have supported the use of BMP-2 in periodontal regeneration, sinus lift bone-grafting and non-unions in oral surgery. Although the use of BMP-2 for bone tissue regeneration has been extensively investigated, the BMP-2-induced osteogenic differentiation of MSCs derived from the umbilical cord has not yet been fully examined. Therefore, in this study, we aimed to examine the effects of BMP-2 on the osteogenic differentiation of MSCs derived from umbilical cord compared to that of MSCs derived from bone marrow. The degree of osteogenic differentiation following BMP-2 treatment was determined by assessing alkaline phosphatase (ALP) activity, and the expression profiles of osteogenic differentiation marker genes, osterix (Osx), Runt-related transcription factor 2 (Runx2) and osteocalcin (Ocn). The results revealed that BMP-2 enhanced the osteogenic differentiation capacity of MSCs derived from both bone marrow and umbilical cord as demonstrated by increased ALP activity and the upregulation of osteogenic differentiation marker genes. The enhancement of the osteogenic differentiation capacity of MSCs by BMP-2 suggests that these MSCs may be used as alternative sources for bone engineering or cell therapy in regenerative medicine.

View Figures

View References

1	Loeser RF: Age-related changes in the musculoskeletal system and the development of osteoarthritis. Clin Geriatr Med. 26:371–386. 2010. View Article : Google Scholar : PubMed/NCBI
2	Petite H, Viateau V, Bensaïd W, Meunier A, de Pollak C, Bourguignon M, Oudina K, Sedel L and Guillemin G: Tissue-engineered bone regeneration. Nat Biotechnol. 18:959–963. 2000. View Article : Google Scholar : PubMed/NCBI
3	Stock UA and Vacanti JP: Tissue engineering: current state and prospects. Annu Rev Med. 52:443–451. 2001. View Article : Google Scholar : PubMed/NCBI
4	Wang XF, Song Y, Liu YS, Sun YC, Wang YG, Wang Y and Lyu PJ: Osteogenic differentiation of three-dimensional bioprinted constructs consisting of human adipose-derived stem cells in vitro and in vivo. PLoS One. 11:e01572142016. View Article : Google Scholar : PubMed/NCBI
5	Yi H, Ur Rehman F, Zhao C, Liu B and He N: Recent advances in nano scaffolds for bone repair. Bone Res. 4:160502016. View Article : Google Scholar : PubMed/NCBI
6	Krampera M, Pizzolo G, Aprili G and Franchini M: Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone. 39:678–683. 2006. View Article : Google Scholar : PubMed/NCBI
7	Krampera M, Marconi S, Pasini A, Galiè M, Rigotti G, Mosna F, Tinelli M, Lovato L, Anghileri E, Andreini A, et al: Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus. Bone. 40:382–390. 2007. View Article : Google Scholar
8	Li X, Ling W, Pennisi A, Wang Y, Khan S, Heidaran M, Pal A, Zhang X, He S, Zeitlin A, et al: Human placenta-derived adherent cells prevent bone loss, stimulate bone formation, and suppress growth of multiple myeloma in bone. Stem Cells. 29:263–273. 2011. View Article : Google Scholar : PubMed/NCBI
9	Arinzeh TL, Peter SJ, Archambault MP, van den Bos C, Gordon S, Kraus K, Smith A and Kadiyala S: Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am. 85-A:1927–1935. 2003. View Article : Google Scholar : PubMed/NCBI
10	Hernigou P, Poignard A, Manicom O, Mathieu G and Rouard H: The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surg Br. 87:896–902. 2005. View Article : Google Scholar : PubMed/NCBI
11	Tseng SS, Lee MA and Reddi AH: Nonunions and the potential of stem cells in fracture-healing. J Bone Joint Surg Am. 90(Suppl 1): 92–98. 2008. View Article : Google Scholar : PubMed/NCBI
12	De Biase P and Capanna R: Clinical applications of BMPs. Injury. 36(Suppl 3): S43–S46. 2005. View Article : Google Scholar : PubMed/NCBI
13	Bais MV, Wigner N, Young M, Toholka R, Graves DT, Morgan EF, Gerstenfeld LC and Einhorn TA: BMP2 is essential for post natal osteogenesis but not for recruitment of osteogenic stem cells. Bone. 45:254–266. 2009. View Article : Google Scholar : PubMed/NCBI
14	Osyczka AM and Leboy PS: Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. Endocrinology. 146:3428–3437. 2005. View Article : Google Scholar : PubMed/NCBI
15	Manochantr S, U-pratya Y, Kheolamai P, Rojphisan S, Chayosumrit M, Tantrawatpan C, Supokawej A and Issaragrisil S: Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord. Intern Med J. 43:430–439. 2013. View Article : Google Scholar
16	Cheng YH, Lin FH, Wang CY, Hsiao CY, Chen HC, Kuo HY, Tsai TF and Chiou SH: Recovery of oxidative stress-induced damage in Cisd2-deficient cardiomyocytes by sustained release of ferulic acid from injectable hydrogel. Biomaterials. 103:207–218. 2016. View Article : Google Scholar : PubMed/NCBI
17	Scarfi S: Use of bone morphogenetic proteins in mesenchymal stem cell stimulation of cartilage and bone repair. World J Stem Cells. 8:1–12. 2016. View Article : Google Scholar : PubMed/NCBI
18	Dang PN, Dwivedi N, Phillips LM, Yu X, Herberg S, Bowerman C, Solorio LD, Murphy WL and Alsberg E: Controlled dual growth factor delivery from microparticles incorporated within human bone marrow-derived mesenchymal stem cell aggregates for enhanced bone tissue engineering via endochondral ossification. Stem Cells Transl Med. 5:206–217. 2016. View Article : Google Scholar :
19	Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
20	Koç ON and Lazarus HM: Mesenchymal stem cells: Heading into the clinic. Bone Marrow Transplant. 27:235–239. 2001. View Article : Google Scholar : PubMed/NCBI
21	Na K, Kim SW, Sun BK, Woo DG, Yang HN, Chung HM and Park KH: Osteogenic differentiation of rabbit mesenchymal stem cells in thermo-reversible hydrogel constructs containing hydroxyapatite and bone morphogenic protein-2 (BMP-2). Biomaterials. 28:2631–2637. 2007. View Article : Google Scholar : PubMed/NCBI
22	Luu HH, Song WX, Luo X, Manning D, Luo J, Deng ZL, Sharff KA, Montag AG, Haydon RC and He TC: Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res. 25:665–677. 2007. View Article : Google Scholar : PubMed/NCBI
23	Osyczka AM, Damek-Poprawa M, Wojtowicz A and Akintoye SO: Age and skeletal sites affect BMP-2 responsiveness of human bone marrow stromal cells. Connect Tissue Res. 50:270–277. 2009. View Article : Google Scholar : PubMed/NCBI
24	Lieberman JR, Daluiski A, Stevenson S, Wu L, McAllister P, Lee YP, Kabo JM, Finerman GA, Berk AJ and Witte ON: The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am. 81:905–917. 1999. View Article : Google Scholar : PubMed/NCBI
25	Lin Z, Wang JS, Lin L, Zhang J, Liu Y, Shuai M and Li Q: Effects of BMP2 and VEGF165 on the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. Exp Ther Med. 7:625–629. 2014.PubMed/NCBI
26	Viateau V1, Guillemin G, Bousson V, Oudina K, Hannouche D, Sedel L, Logeart-Avramoglou D and Petite H: Long-bone critical-size defects treated with tissue-engineered grafts: A study on sheep. J Orthop Res. 25:741–749. 2007. View Article : Google Scholar : PubMed/NCBI
27	Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, Han ZB, Xu ZS, Lu YX, Liu D, et al: Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 91:1017–1026. 2006.PubMed/NCBI
28	Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, Blake J, Schwager C, Eckstein V, Ansorge W, et al: Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol. 33:1402–1416. 2005. View Article : Google Scholar : PubMed/NCBI
29	Kratchmarova I, Blagoev B, Haack-Sorensen M, Kassem M and Mann M: Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science. 308:1472–1477. 2005. View Article : Google Scholar : PubMed/NCBI
30	Hsiao HY, Yang SR, Brey EM, Chu IM and Cheng MH: Hydrogel delivery of mesenchymal stem cell-expressing bone morphogenetic protein-2 enhances bone defect repair. Plast Reconstr Surg Glob Open. 4:e8382016. View Article : Google Scholar : PubMed/NCBI
31	Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj and Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 8:315–317. 2006. View Article : Google Scholar : PubMed/NCBI
32	Mikami Y, Tsuda H, Akiyama Y, Honda M, Shimizu N, Suzuki N and Komiyama K: Alkaline phosphatase determines polyphosphate-induced mineralization in a cell-type independent manner. J Bone Miner Metab. 34:627–637. 2016. View Article : Google Scholar : PubMed/NCBI
33	Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A and Suda T: Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol. 127:1755–1766. 1994. View Article : Google Scholar : PubMed/NCBI
34	Nishimura R, Hata K, Ikeda F, Ichida F, Shimoyama A, Matsubara T, Wada M, Amano K and Yoneda T: Signal transduction and transcriptional regulation during mesenchymal cell differentiation. J Bone Miner Metab. 26:203–212. 2008. View Article : Google Scholar : PubMed/NCBI
35	Ryoo HM, Lee MH and Kim YJ: Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene. 366:51–57. 2006. View Article : Google Scholar
36	Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR and de Crombrugghe B: The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 108:17–29. 2002. View Article : Google Scholar : PubMed/NCBI
37	Tsao YT, Huang YJ, Wu HH, Liu YA, Liu YS and Lee OK: Osteocalcin mediates biomineralization during osteogenic maturation in human mesenchymal stromal cells. Int J Mol Sci. 18:1592017. View Article : Google Scholar :
38	Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, Wozney JM, Kim EG, Choi JY, Ryoo HM and Bae SC: Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol. 20:8783–8792. 2000. View Article : Google Scholar : PubMed/NCBI
39	Kim HJ, Kim JH, Bae SC, Choi JY, Kim HJ and Ryoo HM: The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J Biol Chem. 278:319–326. 2003. View Article : Google Scholar
40	Kim YJ, Lee MH, Wozney JM, Cho JY and Ryoo HM: Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. J Biol Chem. 279:50773–50780. 2004. View Article : Google Scholar : PubMed/NCBI